Phreesia, Inc. (NYSE:PHR) SVP Michael J. Davidoff Sells 1,296 Shares of Stock

Phreesia, Inc. (NYSE:PHRGet Rating) SVP Michael J. Davidoff sold 1,296 shares of the company’s stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $27.60, for a total value of $35,769.60. Following the completion of the sale, the senior vice president now owns 108,312 shares in the company, valued at approximately $2,989,411.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Phreesia Stock Down 1.1 %

PHR stock opened at $27.40 on Tuesday. The business’s 50-day moving average price is $24.69 and its 200-day moving average price is $24.00. The stock has a market cap of $1.44 billion, a P/E ratio of -7.85 and a beta of 0.75. Phreesia, Inc. has a twelve month low of $13.19 and a twelve month high of $76.10. The company has a quick ratio of 4.40, a current ratio of 4.40 and a debt-to-equity ratio of 0.01.

Hedge Funds Weigh In On Phreesia

Hedge funds have recently modified their holdings of the company. Captrust Financial Advisors boosted its holdings in Phreesia by 154.6% in the 2nd quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after buying an additional 866 shares during the period. Assetmark Inc. boosted its stake in shares of Phreesia by 42.2% in the second quarter. Assetmark Inc. now owns 1,685 shares of the company’s stock worth $42,000 after acquiring an additional 500 shares during the period. Advisor Group Holdings Inc. raised its stake in Phreesia by 63.4% during the 4th quarter. Advisor Group Holdings Inc. now owns 1,319 shares of the company’s stock valued at $55,000 after purchasing an additional 512 shares during the period. Hardy Reed LLC purchased a new position in Phreesia in the 1st quarter worth approximately $65,000. Finally, BloombergSen Inc. boosted its stake in Phreesia by 57.1% in the 2nd quarter. BloombergSen Inc. now owns 5,500 shares of the company’s stock worth $138,000 after purchasing an additional 2,000 shares during the period. 89.39% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have commented on PHR. Canaccord Genuity Group dropped their target price on Phreesia from $37.00 to $36.00 and set a “buy” rating on the stock in a report on Thursday, September 8th. Guggenheim upped their target price on shares of Phreesia from $30.00 to $35.00 and gave the stock a “buy” rating in a research note on Thursday, September 8th. SVB Leerink boosted their price objective on shares of Phreesia from $27.00 to $31.00 and gave the stock a “market perform” rating in a report on Thursday, September 8th. Piper Sandler reduced their target price on Phreesia from $42.00 to $32.00 and set an “overweight” rating for the company in a report on Tuesday, June 14th. Finally, KeyCorp initiated coverage on Phreesia in a research report on Thursday, September 15th. They set an “overweight” rating and a $40.00 price objective on the stock. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $36.21.

About Phreesia

(Get Rating)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.

See Also

Insider Buying and Selling by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.